Stuttgart - Delayed Quote EUR
Zealand Pharma A/S (22Z.SG)
60.78
+0.06
+(0.10%)
At close: May 30 at 8:25:12 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-1,207,931
-930,816
-425,668
-942,311
-1,211,971
Investing Cash Flow
-5,399,827
-7,332,915
-1,094,033
281,259
-18,121
Financing Cash Flow
6,466,093
8,288,491
907,014
587,500
1,332,751
End Cash Position
530,729
480,303
449,311
1,069,234
1,129,103
Capital Expenditure
-18,375
-13,148
-23,749
-11,710
-22,133
Issuance of Capital Stock
7,048,480
8,523,479
1,563,950
1,084,661
775,045
Issuance of Debt
0
369,867
0
0
647,906
Repayment of Debt
--
0
-525,764
-436,088
0
Repurchase of Capital Stock
--
-351,834
-41,600
0
-28,590
Free Cash Flow
-1,226,306
-943,964
-449,417
-954,021
-1,234,104
12/31/2021 - 12/23/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RXK3.MU SELLAS Life Sciences Group Inc
1.4940
-2.67%
600161.SS TIANTAN BIO
19.13
-0.52%
GXE.F Galapagos NV
25.16
-1.02%
25I.SG ImmuPharma PLC
0.0210
-20.75%
ATOS.MX Atossa Therapeutics, Inc.
16.00
0.00%
NANOFS.ST Nanoform Finland Oyj
9.98
-1.38%
8GN.F Cessatech A/S
1.6700
0.00%
NVV1.BE Novavax Inc
6.33
+0.91%
BCX.WA Bioceltix S.A.
103.80
-4.07%
FTD.SG Financière de Tubize SA
125.40
+1.29%